54.36
Akero Therapeutics Inc (AKRO) 最新ニュース
Loomis Sayles & Co. L P Acquires 51,850 Shares of Akero Therapeutics, Inc. $AKRO - MarketBeat
SG Americas Securities LLC Sells 1,150,442 Shares of Akero Therapeutics, Inc. $AKRO - MarketBeat
F m Investments LLC Has $960,000 Holdings in Akero Therapeutics, Inc. $AKRO - MarketBeat
Is Akero Therapeutics Inc a good long term investmentMoving Average Strategies & Free High Profit Capital Plays - earlytimes.in
Akero Therapeutics, Inc. (AKRO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
7,107 Shares in Akero Therapeutics, Inc. $AKRO Bought by DLD Asset Management LP - MarketBeat
Rhenman & Partners Asset Management AB Acquires 105,100 Shares of Akero Therapeutics, Inc. $AKRO - MarketBeat
5,700 Shares in Akero Therapeutics, Inc. $AKRO Bought by North Star Asset Management Inc. - MarketBeat
Akero Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akero Therapeutics, Inc.AKRO - Business Wire
(AKRO) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com
Foresite Capital Management VI LLC Has $13.07 Million Stock Holdings in Akero Therapeutics, Inc. $AKRO - MarketBeat
Creative Planning Purchases 25,643 Shares of Akero Therapeutics, Inc. $AKRO - MarketBeat
Ensign Peak Advisors Inc Has $10.05 Million Holdings in Akero Therapeutics, Inc. $AKRO - MarketBeat
What drives Akero Therapeutics Inc 0K4 stock priceAnalyst Upgrades & Fast Growing Stocks - earlytimes.in
Akero Therapeutics, Inc. $AKRO Shares Sold by Geode Capital Management LLC - MarketBeat
Intech Investment Management LLC Sells 16,635 Shares of Akero Therapeutics, Inc. $AKRO - MarketBeat
Will Akero Therapeutics Inc. (0K4) stock outperform value peersPortfolio Profit Report & Daily Oversold Bounce Ideas - newser.com
Halper Sadeh LLC Encourages SEE, AXTA, SEMR, AKRO Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire Inc.
What dividend safety rating applies to Akero Therapeutics Inc. (0K4) stockWeekly Investment Report & Free Reliable Trade Execution Plans - newser.com
Is Akero Therapeutics Inc. stock a smart buy before Fed meetingIndex Update & Risk Controlled Daily Trade Plans - newser.com
Is Akero Therapeutics Inc. (0K4) stock a top pick for value investorsPrice Action & Reliable Price Breakout Signals - newser.com
Is Akero Therapeutics Inc. stock a top pick in earnings seasonTreasury Yields & Daily Profit Focused Screening - newser.com
Can Akero Therapeutics Inc. (0K4) stock deliver strong annual returnsMarket Growth Report & Real-Time Volume Analysis - newser.com
Is Akero Therapeutics Inc. (0K4) stock prepared for digital transitionJuly 2025 Setups & Free Weekly Chart Analysis and Trade Guides - newser.com
Is Akero Therapeutics Inc. stock a buy before product launches2025 Dividend Review & Technical Entry and Exit Alerts - newser.com
Why Akero Therapeutics Inc. (0K4) stock attracts HNW investorsJuly 2025 Final Week & Expert Approved Trade Ideas - newser.com
Is Akero Therapeutics Inc. stock attractive for growth ETFsQuarterly Profit Summary & AI Enhanced Trading Signals - newser.com
Why Akero Therapeutics Inc. stock is recommended by analystsQuarterly Trade Review & Short-Term High Return Strategies - newser.com
Is Akero Therapeutics Inc. stock supported by innovation pipelineJuly 2025 Reactions & Free High Accuracy Swing Entry Alerts - newser.com
Is Akero Therapeutics Inc. stock attractive for income investorsProduct Launch & Advanced Technical Signal Analysis - newser.com
Bank of New York Mellon Corp Increases Stake in Akero Therapeutics, Inc. $AKRO - MarketBeat
Heatmap analysis for Akero Therapeutics Inc. and competitors - newser.com
Is Akero Therapeutics Inc. (0K4) stock a contrarian opportunityPortfolio Value Report & Long Hold Capital Preservation Tips - newser.com
Will Akero Therapeutics Inc. stock keep outperforming rivals2025 Market WrapUp & Daily Profit Maximizing Trade Tips - newser.com
What drives Akero Therapeutics Inc stock priceCurrency Fluctuation Impact & Start Building Capital with Zero Risk - earlytimes.in
Akero Therapeutics shares breakthrough MASH treatment data - Traders Union
大文字化:
|
ボリューム (24 時間):